Comparative bioavailability of two oral formulations manufactured in Mexico containing glyburide and metformin in diabetic patients.
Flores-Murrieta
Francisco J
FJ
fjfloresmurrieta@prodigy.net.mx
Aguilar-Cota
María E
ME
Camacho
Angélica
A
Reyes-García
Gerardo
G
Herrera
Jorge E
JE
Medina-Santillán
Roberto
R
D000368:Aged; D019540:Area Under Curve; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D005260:Female; D005905:Glyburide / Q000493:pharmacokinetics*; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics*; D008687:Metformin / Q000493:pharmacokinetics*; D008800:Mexico; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets
D007004:Hypoglycemic Agents; D013607:Tablets; D008687:Metformin; D005905:Glyburide